Homologous recombination proteins are associated with centrosomes and are required for mitotic stability

Experimental Cell Research

Volumn 317, Issue 8, 2011, Pages 1203-1213

  Cappelli, Enrico ^a,b   Townsend, Stuart ^a,b   Griffin, Carol ^a,b   Thacker, John ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

BRCA1; BRCA2; Centrosomes; Homologous recombination; Mitotic catastrophe; RAD51; RAD51L3; XRCC2

Indexed keywords

BRCA2 PROTEIN; GAMMA TUBULIN; PROTEIN; PROTEIN XRCC2; RAD51 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CENTROSOME; DNA DAMAGE; DYNAMICS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 79953070482     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.01.021     Document Type: Article

References (57)

1. Thacker J. A surfeit of RAD51-like genes?. Trends Genet. 1999, 15:166-168.
2. French C.A., Masson J.Y., Griffin C.S., O'Regan P., West S.C., Thacker J. Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J. Biol. Chem. 2002, 277:19322-19330.
3. Liu Y., Masson J.Y., Shah R., O'Regan P., West S.C. RAD51C is required for Holliday junction processing in mammalian cells. Science 2004, 303:243-246.
4. Sharan S.K., Kuznetsov S.G. Resolving RAD51C function in late stages of homologous recombination. Cell Div. 2007, 2:15.
5. Badie S., Liao C., Thanasoula M., Barber P., Hill M.A., Tarsounas M. RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation. J. Cell Biol. 2009, 185:587-600.
6. West S.C. Molecular views of recombination proteins and their control. Nat. Rev. Mol. Cell Biol. 2003, 4:435-445.
7. Jasin M. Homologous repair of DNA damage and tumorigenesis: the BRCA connection. Oncogene 2002, 21:8981-8993.
8. Lim D.S., Hasty P. A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53. Mol. Cell. Biol. 1996, 16:7133-7143.
9. Tsuzuki T., Fujii Y., Sakumi K., Tominaga Y., Nakao K., Sekiguchi M., Matsushiro A., Yoshimura Y., Morita T. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl Acad. Sci. USA 1996, 93:6236-6240.
10. Deans B., Griffin C.S., Maconochie M., Thacker J. Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice. EMBO J. 2000, 19:6675-6685.
11. Pittman D.L., Schimenti J.C. Midgestation lethality in mice deficient for the RecA-related gene, Rad51d/Rad51l3. Genesis 2000, 26:167-173.
12. Moynahan M.E. The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 2002, 21:8994-9007.
13. Kuznetsov S.G., Haines D.C., Martin B.K., Sharan S.K. Loss of Rad51c leads to embryonic lethality and modulation of Trp53-dependent tumorigenesis in mice. Cancer Res. 2009, 69:863-872.
14. Griffin C.S., Simpson P.J., Wilson C.R., Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat. Cell Biol. 2000, 2:757-761.
15. Xu X., Weaver Z., Linke S.P., Li C., Gotay J., Wang X.W., Harris C.C., Ried T., Deng C.X. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 1999, 3:389-395.
16. Tutt A., Gabriel A., Bertwistle D., Connor F., Paterson H., Peacock J., Ross G., Ashworth A. Absence of Brca2 causes genome instability by chromosome breakage and loss associated with centrosome amplification. Curr. Biol. 1999, 9:1107-1110.
17. Date O., Katsura M., Ishida M., Yoshihara T., Kinomura A., Sueda T., Miyagawa K. Haploinsufficiency of RAD51B causes centrosome fragmentation and aneuploidy in human cells. Cancer Res. 2006, 66:6018-6024.
18. Renglin Lindh A., Schultz N., Saleh-Gohari N., Helleday T. RAD51C (RAD51L2) is involved in maintaining centrosome number in mitosis. Cytogenet. Genome Res. 2007, 116:38-45.
19. Bertrand P., Lambert S., Joubert C., Lopez B.S. Overexpression of mammalian Rad51 does not stimulate tumorigenesis while a dominant-negative Rad51 affects centrosome fragmentation, ploidy and stimulates tumorigenesis, in p53-defective CHO cells. Oncogene 2003, 22:7587-7592.
20. Daboussi F., Thacker J., Lopez B.S. Genetic interactions between RAD51 and its paralogues for centrosome fragmentation and ploidy control, independently of the sensitivity to genotoxic stresses. Oncogene 2005, 24:3691-3696.
21. Dodson H., Bourke E., Jeffers L.J., Vagnarelli P., Sonoda E., Takeda S., Earnshaw W.C., Merdes A., Morrison C. Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J. 2004, 23:3864-3873.
22. Hut H.M., Lemstra W., Blaauw E.H., Van Cappellen G.W., Kampinga H.H., Sibon O.C. Centrosomes split in the presence of impaired DNA integrity during mitosis. Mol. Biol. Cell 2003, 14:1993-2004.
23. Hsu L.C., White R.L. BRCA1 is associated with the centrosome during mitosis. Proc. Natl Acad. Sci. USA 1998, 95:12983-12988.
24. Lotti L.V., Ottini L., D'Amico C., Gradini R., Cama A., Belleudi F., Frati L., Torrisi M.R., Mariani-Costantini R. Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosom. Cancer 2002, 35:193-203.
25. Nakanishi A., Han X., Saito H., Taguchi K., Ohta Y., Imajoh-Ohmi S., Miki Y. Interference with BRCA2, which localizes to the centrosome during S and early M phase, leads to abnormal nuclear division. Biochem. Biophys. Res. Commun. 2007, 355:34-40.
26. Kais Z., Parvin J.D. Regulation of centrosomes by the BRCA1-dependent ubiquitin ligase. Cancer Biol. Ther. 2008, 7:1540-1543.
27. Khodjakov A., Rieder C.L. The sudden recruitment of gamma-tubulin to the centrosome at the onset of mitosis and its dynamic exchange throughout the cell cycle, do not require microtubules. J. Cell Biol. 1999, 146:585-596.
28. Liskay R.M. Absence of a measurable G2 phase in two Chinese hamster cell lines. Proc. Natl Acad. Sci. USA 1977, 74:1622-1625.
29. Roninson I.B., Broude E.V., Chang B.D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Updat. 2001, 4:303-313.
30. Luduena R.F., Roach M.C. Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents. Pharmacol. Ther. 1991, 49:133-152.
31. Cartwright R., Tambini C.E., Simpson P.J., Thacker J. The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/RAD51 family. Nucleic Acids Res. 1998, 26:3084-3089.
32. Braybrooke J.P., Spink K.G., Thacker J., Hickson I.D. The RAD51 family member, RAD51L3, is a DNA-stimulated ATPase that forms a complex with XRCC2. J. Biol. Chem. 2000, 275:29100-29106.
33. Yu D.S., Sonoda E., Takeda S., Huang C.L., Pellegrini L., Blundell T.L., Venkitaraman A.R. Dynamic control of Rad51 recombinase by self-association and interaction with BRCA2. Mol. Cell 2003, 12:1029-1041.
34. Carreira A., Hilario J., Amitani I., Baskin R.J., Shivji M.K., Venkitaraman A.R., Kowalczykowski S.C. The BRC repeats of BRCA2 modulate the DNA-binding selectivity of RAD51. Cell 2009, 136:1032-1043.
35. Deans B., Griffin C.S., O'Regan P., Jasin M., Thacker J. Homologous recombination deficiency leads to profound genetic instability in cells derived from Xrcc2-knockout mice. Cancer Res. 2003, 63:8181-8187.
36. Piel M., Meyer P., Khodjakov A., Rieder C.L., Bornens M. The respective contributions of the mother and daughter centrioles to centrosome activity and behavior in vertebrate cells. J. Cell Biol. 2000, 149:317-330.
37. Bourke E., Dodson H., Merdes A., Cuffe L., Zachos G., Walker M., Gillespie D., Morrison C.G. DNA damage induces Chk1-dependent centrosome amplification. EMBO Rep. 2007, 8:603-609.
38. Katsura M., Tsuruga T., Date O., Yoshihara T., Ishida M., Tomoda Y., Okajima M., Takaku M., Kurumizaka H., Kinomura A., Mishima H.K., Miyagawa K. The ATR-Chk1 pathway plays a role in the generation of centrosome aberrations induced by Rad51C dysfunction. Nucleic Acids Res. 2009, 37:3959-3968.
39. Zhang S., Hemmerich P., Grosse F. Centrosomal localization of DNA damage checkpoint proteins. J. Cell. Biochem. 2007, 101:451-465.
40. Doxsey S., McCollum D., Theurkauf W. Centrosomes in cellular regulation. Annu. Rev. Cell Dev. Biol. 2005, 21:411-434.
41. Loffler H., Bochtler T., Fritz B., Tews B., Ho A.D., Lukas J., Bartek J., Kramer A. DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function. Cell Cycle 2007, 6:2541-2548.
42. Nadezhdina E.S., Fais D., Chentsov Y.S. On the association of centrioles with the interphase nucleus. Eur. J. Cell Biol. 1979, 19:109-115.
43. Robinson J.T., Wojcik E.J., Sanders M.A., McGrail M., Hays T.S. Cytoplasmic dynein is required for the nuclear attachment and migration of centrosomes during mitosis in Drosophila. J. Cell Biol. 1999, 146:597-608.
44. Gonczy P. Centrosomes: hooked on the nucleus. Curr. Biol. 2004, 14:R268-R270.
45. Haber J.E. DNA recombination: the replication connection. Trends Biochem. Sci. 1999, 24:271-275.
46. Andreassen P.R., Ho G.P., D'Andrea A.D. DNA damage responses and their many interactions with the replication fork. Carcinogenesis 2006, 27:883-892.
47. Chan K.L., North P.S., Hickson I.D. BLM is required for faithful chromosome segregation and its localization defines a class of ultrafine anaphase bridges. EMBO J. 2007, 26:3397-3409.
48. Naim V., Rosselli F. The FANC pathway and BLM collaborate during mitosis to prevent micro-nucleation and chromosome abnormalities. Nat. Cell Biol. 2009, 11:761-768.
49. Chan K.L., Palmai-Pallag T., Ying S., Hickson I.D. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat. Cell Biol. 2009, 11:753-760.
50. Daniels M.J., Wang Y., Lee M., Venkitaraman A.R. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science 2004, 306:876-879.
51. Moerner W.E. New directions in single-molecule imaging and analysis. Proc. Natl Acad. Sci. USA 2007, 104:12596-12602.
52. Tambini C.E., Spink K.G., Ross C.J., Hill M.A., Thacker J. The importance of XRCC2 in RAD51-related DNA damage repair. DNA Repair 2010, 9:517-525.
53. Duesberg P., Rasnick D., Li R., Winters L., Rausch C., Hehlmann R. How aneuploidy may cause cancer and genetic instability. Anticancer Res. 1999, 19:4887-4906.
54. Kops G.J., Weaver B.A., Cleveland D.W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer 2005, 5:773-785.
55. Venkitaraman A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 2009, 4:461-487.
56. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nat. Rev. Cancer 2002, 2:815-825.
57. Sluder G., Nordberg J.J. The good, the bad and the ugly: the practical consequences of centrosome amplification. Curr. Opin. Cell Biol. 2004, 16:49-54.